Clearmind Medicine Progresses CMND-100 To Dosing Phase
02 Dec 2025 //
GLOBENEWSWIRE
Hadassah Medical and Bar-Ilan University Collaborate with Immix BioPharma
04 Jan 2023 //
PR NEWSWIRE
NeuroGenesis, HMC Report Positive NF-L Biomarker Results from a Phase 2 Study
01 Mar 2022 //
PRNEWSWIRE

Market Place
Sourcing Support